VANCOUVER, June 27, 2018 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it will file an Investigational New Drug (IND) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback